The brain regions and neuronal processes that underlie addiction extensively overlap with those needed for cognitive functions, including learning, memory, and reasoning. Addiction negatively impacts cognitive functions, making it more challenging to maintain abstinence and potentially leading to progression into neurodegenerative disorders. Furthermore, individuals living with neurodegenerative disorders can engage in behaviors, such as self-medication, due to impaired judgment and impulsivity associated with their condition. Addressing either of these conditions becomes markedly more intricate when they co-occur. This book explores the intricate and often overlooked connection between neurodegenerative disorders and addiction. It delves into the complex interplay between the two areas, discussing preclinical to clinical findings that highlight commonalities, shared risk factors, causality, comorbidity, management, and evidence-based interventions. By examining all these factors, an international team of contributors offer a comprehensive understanding of this underexplored intersection and its profound implications on affected individuals and their families, the healthcare system, and treatment strategies.
Reihe
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Academic, Postgraduate, and Professional Reference
Illustrationen
2 s/w Photographien bzw. Rasterbilder, 1 s/w Zeichnung, 2 s/w Abbildungen, 1 farbige Abbildung
1 Line drawings, black and white; 2 Halftones, black and white; 1 Illustrations, color; 2 Illustrations, black and white
Maße
Höhe: 260 mm
Breite: 183 mm
Dicke: 18 mm
Gewicht
ISBN-13
978-1-032-76242-5 (9781032762425)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Dr. Samer El Hayek, MD, is a specialist psychiatrist at the American Center for Psychiatry and Neurology, Dubai, United Arab Emirates, and an adjunct assistant professor of clinical psychiatry at the American University of Beirut Medical Center (AUBMC), Beirut, Lebanon. An accomplished adult and addiction psychiatrist, Dr. El Hayek brings a robust clinical, academic, and research background to his work.
Dr. El Hayek completed a fellowship in addiction psychiatry at the University of Miami-Jackson Health System in Miami, Florida, United States, in 2022, following a clinical psychiatry residency at AUBMC. With over three years of focused experience in addiction psychiatry, Dr. El Hayek has developed expertise in managing dual diagnoses and implementing patient-centered, multidisciplinary approaches. His clinical practice is informed by his extensive work with individuals from various cultural and socioeconomic backgrounds, underscoring his global perspective and dedication to reducing mental health disparities.
A passionate researcher and thought leader, Dr. El Hayek has authored over 85 peer-reviewed publications, with research interests spanning global mental health, addiction, and stigma. His scholarly contributions have been cited more than 2,000 times, earning him an h-index of 22 by 2024. His research achievements were recognized by his induction into Sigma Xi, The Scientific Research Honor Society, in 2023. He is also the recipient of several awards, including the 2023 Yearly Research Contribution Award from the Erada Center for Treatment and Rehabilitation in Dubai, the 2019 Early-Career Psychiatrists Award from the 15th International Congress on Psychiatry at Ain Shams University in Cairo, and the 2019 Asian Federation of Psychiatric Associations Fellowship Award for Young Psychiatrists at the 7th World Congress of Asian Psychiatry in Melbourne, Australia.
Dr. El Hayek is a board member and the Eastern Mediterranean Region representative for the Network of Early-Career Professionals Working in Addiction Medicine (NECPAM). He also holds editorial roles in several scientific journals, including Frontiers in Public Health and Current Psychopharmacology.
1. Animal models of substance use and neurodegeneration 2. Parkinson's disease and drug addiction 3. Alzheimer's disease and drug addiction 4. Frontotemporal dementia and drug addiction 5. Alcohol and neurodegenerative disorders 6. Cannabis and neurodegenerative disorders 7. Opioids and neurodegenerative disorders 8. Sedatives, hypnotics, and anxiolytics and neurodegenerative disorders 9. Stimulants and neurodegenerative disorders 10. Tobacco and neurodegenerative disorders 11. Behavioral addictions in neurodegenerative diseases 12. Interventions for addiction in neurodegenerative disorders 13. Psychedelic-inspired approaches for treating neurodegenerative disorders.14. PsychedelicInspired Approaches for Treating Neurodegenerative Disorders 15. Environmental Factors and Challenges in Managing Addiction and Neurodegenerative Disorders 16. Challenges of Neurodegenerative and Substance Use Disorders in Low and MiddleIncome Countries 16. Challenges of Neurodegenerative and Substance Use Disorders in Low and MiddleIncome Countries
